The Vida Capital lawsuit was a 2021 securities class action brought by investors in the Vida Longevity Fund, who accused the fund’s management and its founder of misrepresenting how the fund valued its life-settlement assets and hiding a competing firm the founder controlled. Filed in the U.S. District Court for the District of Delaware, the case settled in 2023 for up to $1.4 million.111th. Vida Longevity Investor Settlement
What Investors Alleged
On March 19, 2021, investors Dominic Cardinale, Semyon Rodkin, and Timothy O’Hern filed a class action complaint against the Vida Longevity Fund, Vida Capital Inc., three related Vida entities, and the fund’s founder and former CEO, Jeffrey R. Serra. The case, docketed as 1:21-cv-00402-SRF, alleged violations of the Texas Securities Act based on material misrepresentations and omissions in the fund’s offering documents.2CourtListener. O’Hern v. Vida Longevity Fund LP Docket3Strategic Claims. O’Hern v. Vida Longevity Fund Class Action Complaint
The Vida Longevity Fund launched in 2010 and bought life insurance policies on the secondary market at a discount to face value, aiming to hold them to maturity. It hit its 8% to 12% return target through 2017, then slid. Returns fell to 5.65% in 2018 and 5.49% in 2019, then dropped to negative 12.66% in 2020. A change to life expectancy assumptions in the fourth quarter of 2020 forced a 10.3% write-down.3Strategic Claims. O’Hern v. Vida Longevity Fund Class Action Complaint4S&P Global. Vida Capital Inc. Regulatory Article
Valuation and Pricing Failures
The complaint alleged the fund’s proprietary pricing algorithm, called Delta, was “wholly inadequate,” that life expectancy reports on some policies were more than 36 months old, and that outdated actuarial modeling produced “negative aging effects” across the portfolio. Investors also alleged the fund lacked proper separation between underwriting and origination and was understaffed in risk and portfolio management. Management acknowledged the problems in 2020, according to the complaint, calling it a “fix and correct” year, updating medical records for most of the portfolio and acquiring Avmont LLC to rebuild its investment and underwriting capabilities.3Strategic Claims. O’Hern v. Vida Longevity Fund Class Action Complaint
Serra’s Competing Firm
The sharper allegations concerned Serra himself. The complaint said he held a 50% ownership stake in Ovation Partners LP, an investment firm he cofounded in 2010 that invested in life settlements and other alternative assets, putting it in direct competition with the Vida Longevity Fund. The two entities shared an Austin office, some employees, certain broker-dealers, and the same life settlement originator, Magna Life Settlements. Because Serra controlled both, the complaint alleged, he decided which entity received the most profitable policies. None of this was disclosed in the fund’s private placement memorandum.3Strategic Claims. O’Hern v. Vida Longevity Fund Class Action Complaint5PR Newswire. Vida Longevity Investors File Suit Against Vida Companies
The complaint further alleged that Ovation held more than $40 million in the Vida Longevity Fund and pulled its entire position out during 2018 in three tranches, which reportedly accounted for 45%, 70%, and 26% of the fund’s total redemptions in the respective reporting periods. Serra oversaw those withdrawals, the complaint said, while continuing to urge outside investors to put money in, and the redemption activity was concealed from the investing public.3Strategic Claims. O’Hern v. Vida Longevity Fund Class Action Complaint
How the Settlement Worked
The parties reached a settlement in July 2022. Judge Sherry R. Fallon granted preliminary approval on November 21, 2022, held a fairness hearing on April 18, 2023, and the case was terminated on May 2, 2023.2CourtListener. O’Hern v. Vida Longevity Fund LP Docket
The fund and its management agreed to pay up to $1.4 million. The settlement class covered people and entities that purchased or acquired interests in the Vida Longevity Fund between January 1, 2017, and March 19, 2021, with payouts distributed based on the number of claims filed.111th. Vida Longevity Investor Settlement
Related Cases
The O’Hern class action was not the only litigation. In September 2021, an investor filed a derivative lawsuit against Vida Capital in Delaware’s Chancery Court, alleging that company leaders “siphoned millions” from the fund while knowing it was overvalued and then implemented “overdue actuarial fixes” that caused the fund’s value to plummet.6Law360. Vida Capital Investor Sues Over Life Settlement Fund
In December 2024, the Estate of Sheila Shane sued the company under its new name, Obra Capital Inc., along with Wilmington Trust N.A., Vida Capital LLC, Obra Capital Management LLC, Vida Longevity Fund LP, and two closed-end fund trusts (VICOF II Trust and VICOF III Trust) in the Complex Commercial Litigation Division of Delaware Superior Court. Several defendants were voluntarily dismissed in February 2025, and the case was marked settled on February 18, 2026, and closed the next day. Settlement terms were not disclosed.7Delaware Courts. Estate of Sheila Shane v. Obra Capital Docket
The Rebrand to Obra Capital and a Separate SEC Order
On December 14, 2022, Vida Capital Inc. rebranded as Obra Capital Inc. The company said the new name reflected its business evolution, expanded asset management strategies, and new leadership. At the time it managed roughly $3.9 billion to $4 billion in assets and was a portfolio company of RedBird Capital Partners and Reverence Capital Partners.8Obra Capital. Vida Capital Rebrands to Become Obra Capital9Artemis. Vida Rebrands to Obra Capital, Launches Insurance Special Situations Strategy
In August 2024, the SEC issued an administrative order against Obra Capital Management LLC (formerly Vida Capital Management LLC) for violating the pay-to-play rule under the Investment Advisers Act. A campaign contribution by someone who later became a “covered associate” at the firm triggered a prohibited period, during which the firm continued to provide paid advisory services to a Michigan public pension fund. Obra was censured, ordered to cease and desist, and fined $95,000. As of its March 2024 Form ADV filing, the firm reported roughly $2.7 billion in regulatory assets under management and remained SEC-registered.10SEC. SEC Administrative Proceeding Release No. IA-6662
The SEC action is separate from the investor class action; it involves campaign-finance compliance rather than the valuation and conflict-of-interest claims that drove the O’Hern case.